Guidelines for development of a core outcome set for clinical trials of post-inflammatory hyperpigmentation |
Columnist
eMediNexus Coverage from: 
Guidelines for development of a core outcome set for clinical trials of post-inflammatory hyperpigmentation

0 Read Comments                

Post-inflammatory hyperpigmentation (PIH) is the most common disorder and presents a complaint of pigmentation, especially in people with skin of color. PIH is associated with a significant psychological burden and decreasein the quality of life. The management options for post- inflammatory hyperpigmentation include topical lightening agents, photoprotection, lasers and energy devices. The clinical trials of melasma have reported a diversity of outcomes, often hindering the synthesis o...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now